Primary |
Nausea |
33.7% |
Vomiting |
24.4% |
Depression |
7.0% |
Product Used For Unknown Indication |
7.0% |
Pain |
4.7% |
Hyperemesis Gravidarum |
3.5% |
Migraine |
3.5% |
Mueller's Mixed Tumour |
2.3% |
Back Pain |
1.2% |
Diarrhoea |
1.2% |
Drug Use For Unknown Indication |
1.2% |
Gastroenteritis Viral |
1.2% |
Hiv Infection |
1.2% |
Macular Degeneration |
1.2% |
Migraine Prophylaxis |
1.2% |
Neoplasm Malignant |
1.2% |
Pelvic Pain |
1.2% |
Pregnancy |
1.2% |
Procedural Nausea |
1.2% |
Procedural Pain |
1.2% |
|
Vomiting |
18.8% |
Tremor |
10.4% |
Dystonia |
6.3% |
Medication Error |
6.3% |
Neuroleptic Malignant Syndrome |
6.3% |
Suicidal Ideation |
6.3% |
Swollen Tongue |
6.3% |
Trismus |
6.3% |
Muscle Spasms |
4.2% |
Musculoskeletal Stiffness |
4.2% |
Pyrexia |
4.2% |
Tardive Dyskinesia |
4.2% |
Cardiac Arrest |
2.1% |
Cardio-respiratory Arrest |
2.1% |
Convulsion |
2.1% |
Decreased Appetite |
2.1% |
Depression |
2.1% |
Dyskinesia |
2.1% |
Feeling Abnormal |
2.1% |
Grand Mal Convulsion |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
39.1% |
Drug Use For Unknown Indication |
13.5% |
Vomiting |
7.8% |
Pain |
5.4% |
Nausea |
4.5% |
Drug Exposure During Pregnancy |
4.1% |
Vertigo |
4.0% |
Breast Cancer |
3.3% |
Cancer Pain |
2.4% |
Depression |
1.9% |
Pruritus |
1.9% |
Foetal Exposure During Pregnancy |
1.6% |
Rheumatoid Arthritis |
1.6% |
Skin Ulcer |
1.6% |
Hyperemesis Gravidarum |
1.5% |
Acute Myeloid Leukaemia |
1.3% |
Constipation |
1.3% |
Pyrexia |
1.2% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Hypertension |
1.1% |
|
Completed Suicide |
25.2% |
Vomiting |
12.9% |
Somnolence |
6.5% |
Toxicity To Various Agents |
6.5% |
Suicidal Ideation |
5.0% |
Drug Ineffective |
4.3% |
Respiratory Arrest |
4.3% |
Serotonin Syndrome |
4.3% |
Depression |
2.9% |
Intentional Drug Misuse |
2.9% |
Necrotising Enterocolitis Neonatal |
2.9% |
Pancytopenia |
2.9% |
Talipes |
2.9% |
Tremor |
2.9% |
Ulcer |
2.9% |
Drug Hypersensitivity |
2.2% |
Drug Toxicity |
2.2% |
Unresponsive To Stimuli |
2.2% |
Urinary Tract Infection |
2.2% |
Weight Decreased |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
31.3% |
Drug Use For Unknown Indication |
16.2% |
Nausea |
8.5% |
Prophylaxis |
6.6% |
Pain |
6.5% |
Multiple Myeloma |
3.5% |
Non-small Cell Lung Cancer |
3.3% |
Hypertension |
3.3% |
Breast Cancer |
3.2% |
Constipation |
2.9% |
Vomiting |
2.8% |
Depression |
1.8% |
Cancer Pain |
1.7% |
Anxiety |
1.6% |
Gastrooesophageal Reflux Disease |
1.3% |
Insomnia |
1.2% |
Colorectal Cancer Metastatic |
1.2% |
Metastases To Bone |
1.1% |
Premedication |
1.0% |
Back Pain |
1.0% |
|
Vomiting |
19.7% |
Death |
8.4% |
Weight Decreased |
6.9% |
Thrombocytopenia |
6.7% |
Renal Failure Acute |
6.3% |
White Blood Cell Count Decreased |
5.8% |
Pneumonia |
5.1% |
Pyrexia |
4.4% |
Nausea |
4.3% |
Sepsis |
3.7% |
Pulmonary Embolism |
3.5% |
Urinary Tract Infection |
3.2% |
Dyspnoea |
3.0% |
Diarrhoea |
3.0% |
Syncope |
2.9% |
Pleural Effusion |
2.8% |
Vision Blurred |
2.8% |
Neutropenia |
2.5% |
Pain |
2.5% |
Renal Failure |
2.4% |
|
Interacting |
Product Used For Unknown Indication |
38.7% |
Epilepsy |
12.9% |
Nausea |
9.7% |
Depression |
6.5% |
Vertigo |
6.5% |
Vomiting |
6.5% |
Colon Cancer |
3.2% |
Convulsion |
3.2% |
Ear Infection |
3.2% |
Pruritus |
3.2% |
Skin Ulcer |
3.2% |
Sleep Disorder |
3.2% |
|
Serotonin Syndrome |
28.6% |
Constipation |
14.3% |
Convulsion |
14.3% |
Drug Interaction |
14.3% |
Dystonia |
14.3% |
Tonic Convulsion |
14.3% |
|